TC, I thought about Joe's relationship to GNBT in
Post# of 36566
(Total Views: 376)
Posted On: 10/20/2020 1:33:50 PM
TC, I thought about Joe's relationship to GNBT in the past, and it's effect on pps as well. But I discarded it as a negative because 1) he was just a consultant - ie, no decision making ability and 2) we don't know what he was recommending in detail. He did say many times during his tenure with MF, the "corporate structure had to be cleaned up" before any real progress could be made. So that's consistent with what he did AFTER he became the power on the throne, not just an advisor to the throne. And his actions since becoming the Chief, A No. 1, king of the hill, the Big Kahuna, and Chairmen of the Board (old guy references, again!) have certainly been in line with those statements from many moons ago.
I believe the issue with the peptides is simply one of confidentiality. Joe is trying to sell the concept (and the actual process) to countries/agencies that probably have never heard of the concept before - I sure don't see Pfizer, Moderna or J&J talking about them with regards to their vaccine efforts. So maybe GNBT is trying to keep the competitive edge without broadcasting their success, ie, showing specific entities the current status (results?) confidentially, but keeping the rest from the public eye. Joe is not adverse to playing the long game - we've seen that before with how's he gone about where we are now. So he may be trading short term gain for long term prosperity by holding back info that COULD be shared, but isn't REQUIRED to be shared.
I think of this in terms of Intel in the 1990's and early 2000's - everyone knew they were working on faster and better chips, but Intel certainly wasn't telling the world exactly what they were working on until they could deliver a use for that chip. Joe's nobody's dummy - I believe he understands that strategy and is pursuing it, while keeping us up to date on the other big things GNBT and NGIO are doing. And since he now believes he has the funding for those other aspects of the companies, why advertise something that MIGHT boost the pps a little but give away even a small aspect of a process that they might want to keep confidential, at least until they have a real use for the process?
My theory, anyway. Just like Joe's trip to NY - I believe it is part of the dog and pony show to estimate the value of NGIO, to line up initial buyers and to establish an IPO price. But I don't KNOW that to be true, and I doubt Joe will say anything until the deal is done. Long game vs short term game. You and me have waited this long - I figure I might as well wait another couple of weeks or months and just not worry about it. Others may see it differently, and that view may end up being more correct than mine.
I believe the issue with the peptides is simply one of confidentiality. Joe is trying to sell the concept (and the actual process) to countries/agencies that probably have never heard of the concept before - I sure don't see Pfizer, Moderna or J&J talking about them with regards to their vaccine efforts. So maybe GNBT is trying to keep the competitive edge without broadcasting their success, ie, showing specific entities the current status (results?) confidentially, but keeping the rest from the public eye. Joe is not adverse to playing the long game - we've seen that before with how's he gone about where we are now. So he may be trading short term gain for long term prosperity by holding back info that COULD be shared, but isn't REQUIRED to be shared.
I think of this in terms of Intel in the 1990's and early 2000's - everyone knew they were working on faster and better chips, but Intel certainly wasn't telling the world exactly what they were working on until they could deliver a use for that chip. Joe's nobody's dummy - I believe he understands that strategy and is pursuing it, while keeping us up to date on the other big things GNBT and NGIO are doing. And since he now believes he has the funding for those other aspects of the companies, why advertise something that MIGHT boost the pps a little but give away even a small aspect of a process that they might want to keep confidential, at least until they have a real use for the process?
My theory, anyway. Just like Joe's trip to NY - I believe it is part of the dog and pony show to estimate the value of NGIO, to line up initial buyers and to establish an IPO price. But I don't KNOW that to be true, and I doubt Joe will say anything until the deal is done. Long game vs short term game. You and me have waited this long - I figure I might as well wait another couple of weeks or months and just not worry about it. Others may see it differently, and that view may end up being more correct than mine.
(2)
(0)